Drug shortage
Furosemide Injection · Eugia US LLC
FDA drug shortage · Current · updated Apr 10, 2025
Key facts
| Generic name | Furosemide Injection |
|---|---|
| Proprietary name | Furosemide |
| Company | Eugia US LLC |
| Presentation | Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) |
| Dosage form | Injection |
| Strength | 40 mg/4 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Cardiovascular |
| Package NDCs | 55150-323-25 |
| First posted | Apr 7, 2020 |
| Last updated | Apr 10, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: